China SXT Pharmaceuticals, Inc.
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2022 | 48.1% | -199.4% | -220.4% |
| FY2023 | 21.6% | -284.4% | -301.0% |
| FY2024 | 28.7% | -130.4% | -160.7% |
| FY2025 | 21.1% | -154.0% | -189.8% |
| FY2026 | 21.9% | -625.9% | -545.2% |
Profit Margins
| Fiscal Year | Gross Margin | Operating Margin | Net Margin |
|---|---|---|---|
| FY2022 | 48.1% | -199.4% | -220.4% |
| FY2023 | 21.6% | -284.4% | -301.0% |
| FY2024 | 28.7% | -130.4% | -160.7% |
| FY2025 | 21.1% | -154.0% | -189.8% |
| FY2026 | 21.9% | -625.9% | -545.2% |